Group 1: MiniMed IPO Details - MiniMed, a spin-off from Medtronic focused on integrated diabetes management, plans to raise $742 million through an IPO by issuing 28 million shares priced between $25 and $28 each [1][2] - The company reported a revenue of $2.9 billion for the 12 months ending October 31, 2025, and aims to list on NASDAQ under the ticker symbol MMED [2] - As of October 2025, MiniMed has over 640,000 insulin pump users, with a continuous glucose monitoring (CGM) installation rate of 65%, up from 58% year-over-year [1] Group 2: Dune Acquisition III IPO Details - Dune Acquisition III, a SPAC targeting investments in digital assets, sports entertainment, SaaS, and AI, has filed for an IPO to raise up to $150 million by issuing 15 million shares at $10 each [3] - Each share unit will include one common share and one-third of a warrant, with an exercise price of $11.50 per share [3] - The SPAC is led by CEO Carter Glatt and CFO Jeron Smith, with a focus on sectors such as digital assets and artificial intelligence [3]